期刊文献+

二氧化钛光催化降解双酚AF研究 被引量:2

Photocatalytic Degradation of Bisphenol AF in TiO_2 Suspension
下载PDF
导出
摘要 系统研究了双酚AF在二氧化钛溶液中的光催化降解行为。就溶解氧、二氧化钛投加量、氟离子浓度和双酚AF的初始浓度等因素对双酚AF降解的影响进行了详细讨论。研究重点是双酚AF的降解动力学以及在降解过程中所产生的氟离子浓度。当双酚AF的初始浓度是40μmol/L时,经过540 min的光催化降解,反应体系的总有机碳去除率超过97%,此时溶液中氟离子的浓度为0.98 mg/L。双酚AF在二氧化钛溶液中的降解符合Langmuir-Hinshelwood动力学模型,其降解动力学常数是1.21μmol/(L·min)。结果表明,二氧化钛光催化可以有效的去除双酚AF,并且不产生其它二次污染物。 Photodegradation behavior of bisphenol AF (BPAF) in TiO2 suspension was investigated. Influence of dissolved oxygen, TiO2 dosage, fluoride and initial BPAF concentration on the degradation of BPAF was studied and described in details. The degradation kinetics of BPAF and the fluoride concentration during the degradation were focused. At an initial concentration of 40 μmol/L, more than 97% of TOC was removed within 540 min irradiation in the fluoride concentration of 0.98 mg/L. Degradation of BPAF followed the Langmuir-Hinshelwood kinetics rate model and reaction rate constant was 1.21 μmol/(L·min). Results indicated that TiO2 photocatalytic degradation is a highly effective way to remove BPAF without any generation of more toxic products or fluoride pollution.
作者 王品文
出处 《环境科学与技术》 CAS CSCD 北大核心 2012年第12期254-257,共4页 Environmental Science & Technology
关键词 双酚AF 内分泌干扰物 二氧化钛 bisphenol AF EDCs fluoride TiO2
  • 相关文献

参考文献13

  • 1Boyd GR,Reemtsma H,Grimm DA,et al.Pharmaceuticals and personal care products(PPCPs)in surface and treated waters of Louisiana,USA and Ontario,Canada[J].The Science of the Total Environment,2003,311(1-3):135-149.
  • 2Debska J,Kot-Wasik A,Namiesnik J.Fate and analysis of pharmaceutical residues in the aquatic environment[J].Crit Rev Anal Chem,2004,34(1):51-67.
  • 3Nikolaou A,Meric S,Fatta D.Occurrence patterns of phar-maceuticals in water and wastewater environments[J].Anal Bioanal Chem,2007,387(4):1225-1234.
  • 4Soliman MA,Pedersen JA,Park H,et al.Human pharma-ceuticals,antioxidants and plasticizers in wastewater treat-ment plant and water reclamation plant effluents[J].Water En-viron Res,2007,79(2):156-167.
  • 5Benotti MJ,Trenholm RA,Vanderford BJ,et al.Pharma-ceuticals and endocrine disrupting compounds in U S drink-ing water[J].Environ Sci Technol,2008,43(3):597-603.
  • 6Fent K,Weston AA,Caminada D.Ecotoxicology of human pharmaceuticals[J].Aquat Toxicol,2006,76(2):122-159.
  • 7McAvoy DC,Schatowitz B,Jacob M,et al.Measurement of triclosan in wastewater treatment systems[J].Environ Tox-icol Chem,2002,21(7):1323-1329.
  • 8G觟bel A,McArdell CS,Joss A,et al.Fate of sulfonamides,macrolides and trimethoprim in different wastewater treat-ment technologies[J].Sci Total Environ,2007,372(2-3):361-371.
  • 9Onesios K,Yu J,Bouwer E.Biodegradation and removal of pharmaceuticals and personal care products in treatment systems:a review[J].Biodegradation,2009,20(4):441-466.
  • 10Vieno N,Tuhkanen T,Kronberg L.Elimination of phar-maceuticals in sewage treatment plants in Finland[J].Water Res,2007,41(5):1001-1012.

同被引文献87

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部